Case fatality rate

From WikiMD's WELLNESSPEDIA

Case Fatality Rate (CFR)

The Case Fatality Rate (CFR) is a measure used in epidemiology to determine the severity of a disease. It represents the proportion of individuals diagnosed with a particular disease who die from that disease within a specified period. The CFR is typically expressed as a percentage and is calculated using the following formula:

CFR=(Number of deaths from the diseaseNumber of diagnosed cases of the disease)×100%

Calculation[edit]

To calculate the CFR, accurate data on both the number of diagnosed cases and the number of deaths caused by the disease are required. The formula is straightforward:

CFR=(DN)×100%

where:

  • D is the number of deaths due to the disease.
  • N is the number of diagnosed cases of the disease.

Importance[edit]

The CFR is an important metric in public health and epidemiology because it helps to assess the lethality of a disease. It is particularly useful during outbreaks and epidemics to understand the impact of the disease on the affected population. A high CFR indicates a more lethal disease, while a low CFR suggests a less severe disease.

Factors Affecting CFR[edit]

Several factors can influence the CFR, including:

Comparison with Mortality Rate[edit]

The CFR should not be confused with the mortality rate, which measures the number of deaths in a given population over a specific period. While the CFR focuses on the proportion of deaths among diagnosed cases, the mortality rate considers the entire population, including those not diagnosed with the disease.

Examples[edit]

Limitations[edit]

The CFR has limitations, particularly during the early stages of an outbreak when data may be incomplete or inaccurate. Underreporting of cases or deaths can lead to an inaccurate CFR. Additionally, the CFR does not account for the duration of the disease or the time lag between diagnosis and death.

Related Pages[edit]

See Also[edit]




Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.